| Stage | PTCT | % of rev | GKOS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $361M | 100.00% | $211M | 100.00% | PTCT ×1.71 |
| Gross profit | $341M | 94.47% | $180M | 85.23% | PTCT +9.2pp |
| Operating income | $149M | 41.32% | $828,000 | 0.39% | PTCT +40.9pp |
| Pre-tax income | $98M | 27.06% | $2M | 1.10% | PTCT +26.0pp |
| Net income | $83M | 23.16% | $2M | 0.96% | PTCT +22.2pp |
| Stage | PTCT | GKOS | Gap · A − B |
|---|---|---|---|
| Revenue | $361M100.00% | $211M100.00% | PTCT ×1.71 |
| Gross profit | 94.47%$341M | 85.23%$180M | PTCT +9.2pp |
| Operating income | 41.32%$149M | 0.39%$828,000 | PTCT +40.9pp |
| Pre-tax income | 27.06%$98M | 1.10%$2M | PTCT +26.0pp |
| Net income |
| 23.16%$83M |
| 0.96%$2M |
| PTCT +22.2pp |
No disclosed counterparties: GKOS.
None